Adam Friedman, MD, FAAD
Adam Friedman, MD, FAAD is Professor and Chair of Dermatology and serves as Associate Residency Program Director, Director of Translational Research, and Director of the Supportive Oncodermatology Program in the Department of Dermatology at The George Washington University School of Medicine & Health Sciences.
Dr. Friedman is currently investigating novel nanotechnologies that allow for controlled and sustained delivery of a wide spectrum of physiologically and medicinally relevant molecules, with an emphasis on treating infectious diseases, accelerating wound healing, immune modulation, and correcting vascular dysfunction. More recently, he has emerged as leader in the field of medical cannabis in dermatology. He holds multiple patents derived from these investigations, and has published over 210 papers/chapters and 2 textbooks on both his research as well as a variety of clinical areas in dermatology with an emphasis on emerging medical therapies. He has received multiple awards such as the DermaCare Access Network Advocacy Leader Award, American Dermatologic Association Young Leader Award, the American Society for Dermatologic Surgery Cutting Edge Research Award, the Elle Beauty Genius Award, the Journal of Drugs Innovations in Residency Teaching Award, and has been on the Washingtonian Top Doctors list since 2017.
Dr. Friedman is also committed to resident and medical education. He hosts two online series titled “Ask an Expert” and “Ask Dr. Friedman,” as well as the JDD Podcast “Ask the Investigator”. He currently serves as President of the Derma Care Access Network, a subgroup of the Alliance for Patient Access, the chair of the AAD Poster Task Force, is the medical director of ODAC conference, senior editor of the Dermatology In-Review, Krazy Kodachromes, and director of the Oakstone Institute’s Dermatology Board Review and Dermatology for Primary Care series.